Unity Biotechnology Inc (UBX)
1.22
-0.03
(-2.40%)
USD |
NASDAQ |
Nov 05, 11:26
Unity Biotechnology Total Liabilities (Quarterly): 33.77M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 33.77M |
| March 31, 2024 | 34.88M |
| December 31, 2023 | 37.29M |
| September 30, 2023 | 33.06M |
| June 30, 2023 | 51.60M |
| March 31, 2023 | 55.63M |
| December 31, 2022 | 68.27M |
| September 30, 2022 | 57.83M |
| June 30, 2022 | 57.66M |
| March 31, 2022 | 61.78M |
| December 31, 2021 | 65.14M |
| September 30, 2021 | 67.95M |
| June 30, 2021 | 70.35M |
| March 31, 2021 | 68.23M |
| Date | Value |
|---|---|
| December 31, 2020 | 73.44M |
| September 30, 2020 | 76.87M |
| June 30, 2020 | 52.44M |
| March 31, 2020 | 52.46M |
| December 31, 2019 | 30.51M |
| September 30, 2019 | 26.96M |
| June 30, 2019 | 27.16M |
| March 31, 2019 | 14.19M |
| December 31, 2018 | 20.68M |
| September 30, 2018 | 15.20M |
| June 30, 2018 | 13.39M |
| March 31, 2018 | 242.73M |
| December 31, 2017 | 185.14M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
30.51M
Minimum
Dec 2019
76.87M
Maximum
Sep 2020
55.22M
Average
57.66M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 44.92M |
| Electromed Inc | 7.689M |
| Xtant Medical Holdings Inc | 50.57M |
| Myomo Inc | 6.513M |
| Catheter Precision Inc | 11.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 53.52M |
| Shareholders Equity (Quarterly) | 19.75M |